It’s seldom that drug companies have the opportunity to develop a product that’s relevant to the entire world. In fact, it takes a global pandemic. IQVIA Institute for Human Data Science took on the task of estimating the financial impact of protecting the population from COVID-19, and the numbers are staggering. According to a recent FiercePharma article that discussed the figures, global vaccine sales will reach $157B by 2025. This estimate accounts for dramatic drops in the cost per dose going from an average of $22 per shot in 2021 to $9 per shot in 2023.
COVID-19 Vaccine Sales Projections are Impressive
Pharmaceutical companies that invested in coronavirus vaccine development will see big revenues.
May 4, 2021
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
Break out of the ordinary: see what’s new in life sciences packaging
<strong>At PACK EXPO Las Vegas, you’ll see machinery in action and new tech from 2,300 suppliers, collaborate with experts and explore transformative solutions. Join us in September to experience a breakthrough for life sciences products.</strong>
REGISTER NOW & SAVE!